Cargando…

Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia

Detalles Bibliográficos
Autor principal:	Ferrer, Gerardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197750/ https://www.ncbi.nlm.nih.gov/pubmed/30219356 http://dx.doi.org/10.1016/j.ebiom.2018.09.008

Ejemplares similares

Initial Rate of BCR::ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia
por: Branford, Susan
Publicado: (2022)

P603: INFECTIONS BEFORE AND DURING IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
por: Brieghel, Christian, et al.
Publicado: (2023)

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
por: Khan, Sujoy, et al.
Publicado: (2023)

FcγRIIb-BCR coligation inhibits B-cell receptor signaling in chronic lymphocytic leukemia
por: Bosch, Rosa, et al.
Publicado: (2020)

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia
por: Smith, Lindsay D., et al.
Publicado: (2019)

Highlights: B-chronic lymphocytic leukemia: Current diagnostic characteristics of and treatments for chronic lymphocytic leukemia in Japan
por: Aoki, Sadao
Publicado: (2020)

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia
por: Mustafa, S. Shahzad, et al.
Publicado: (2021)

Lipids and Their Effects in Chronic Lymphocytic Leukemia
por: Friedman, Daphne R.
Publicado: (2016)

TOSO interacts with SYK and enhances BCR pathway activation in chronic lymphocytic leukemia
por: Zhang, Yan-Ru, et al.
Publicado: (2020)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
por: Noto, Alessandro, et al.
Publicado: (2023)

Phosphoinositide 3′-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia
por: Hoellenriegel, Julia, et al.
Publicado: (2011)

BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo
por: Schleiss, Cédric, et al.
Publicado: (2019)

The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia
Publicado: (1981)

Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia
por: Kasar, S., et al.
Publicado: (2016)

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib
por: Jackson, Ross A., et al.
Publicado: (2023)

A decade of CD4+ chimeric antigen receptor T-cell evolution in two chronic lymphocytic leukemia patients: were chronic lymphocytic leukemia cells present?
por: Bouzianas, Dimitrios, et al.
Publicado: (2023)

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia
por: Falchi, Lorenzo, et al.
Publicado: (2016)

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
por: Konovalova, Angelina, et al.
Publicado: (2023)

Immunoglobulin heavy variable somatic hyper mutation status in chronic lymphocytic leukaemia: on the threshold of a new era?
por: Langerak, Anton W., et al.
Publicado: (2020)

CHARACTERIZATION OF IMMUNOGLOBULIN STRUCTURES FROM THE SURFACE OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
por: Eskeland, Trond, et al.
Publicado: (1971)

Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia
por: Marinelli, Marilisa, et al.
Publicado: (2016)

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2021)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
por: Colado, Ana, et al.
Publicado: (2021)

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
por: Polillo, Marialuisa, et al.
Publicado: (2015)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia
por: Natarajan, Aparna, et al.
Publicado: (2019)

Immunoglobulin Infusion as Therapy Against Influenza?
por: Huckriede, Anke
Publicado: (2017)

First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia
por: Zhang, Xueya, et al.
Publicado: (2019)

Ibrutinib continues to influence the therapeutic landscape of chronic lymphocytic leukemia: new data presented at ASCO 2017
por: Molica, Stefano
Publicado: (2017)

Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
por: Tuscano, Joseph, et al.
Publicado: (2020)

Targeting the PTP1B‐Bcr‐Abl1 interaction for the degradation of T315I mutant Bcr‐Abl1 in chronic myeloid leukemia
por: Elgehama, Ahmed, et al.
Publicado: (2022)

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
por: Rosenquist, R, et al.
Publicado: (2017)

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
por: Davi, Frédéric, et al.
Publicado: (2020)

Immunoglobulin Gene Sequence as an Inherited and Acquired Risk Factor for Chronic Lymphocytic Leukemia
por: Datta, Moumita, et al.
Publicado: (2022)

BCR::ABL1 transcripts and clinical outcome ‐ interrogating the technique
por: Branford, Susan
Publicado: (2022)

BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2014)

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
por: Ross, Theodora S, et al.
Publicado: (2014)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
por: Loscocco, Federica, et al.
Publicado: (2019)

Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
por: Martini, Veronica, et al.
Publicado: (2018)

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
por: Volz, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_moge3km3b496srgvosvtcdc7m5